The rapid integration of generative artificial intelligence into the healthcare sector has created a burgeoning phenomenon known as shadow AI, where frontline clinicians utilize unvetted, consumer-grade tools to manage clinical tasks and administrative burdens. While these tools offer immediate relief to a workforce plagued by burnout, they operate outside the traditional safety and governance structures […]
The pharmaceutical industry is currently navigating a period of unprecedented transformation, driven by a convergence of technological advancement, regulatory tightening, and a fundamental shift in how healthcare professionals (HCPs) and patients consume information. As pharmaceutical marketers face increasing pressure to demonstrate a direct correlation between media expenditures and clinical outcomes—specifically script lift and qualified HCP […]
The digital transformation of the healthcare industry, catalyzed by the rapid adoption of Electronic Health Records (EHR) in the early 2000s, has reached a critical inflection point where the demand for a streamlined user experience is clashing with the inherent complexity of medical practice. For more than two decades, healthcare personnel have navigated a landscape […]
Interra Health, a leading health technology platform specializing in optimized prescribing solutions, has officially announced its comprehensive support for the Medicare GLP-1 Bridge program. This strategic integration is designed to streamline the delivery of high-demand weight loss medications to eligible seniors, addressing one of the most significant cost barriers in modern geriatric care. By embedding […]
New York-based healthcare technology firm Inspiren has successfully closed a $70 million Series C funding round, marking a significant milestone in the integration of ambient artificial intelligence within the senior living sector. The investment round, led by NewView Capital, brings the company’s total capital raised to date to $225 million and establishes a post-money valuation […]
The U.S. Food and Drug Administration (FDA) has granted approval to Zanvastro (zilganersen), the first-ever therapy specifically indicated for the treatment of Alexander disease in both pediatric and adult patients. Developed by Carlsbad, California-based Ionis Pharmaceuticals, Zanvastro is a genetic medicine designed to target the underlying biological cause of this ultra-rare and life-threatening neurological disorder. […]
The House Veterans’ Affairs Committee has taken the extraordinary step of issuing subpoenas to the highest levels of Oracle Health leadership following a breakdown in transparency regarding the Department of Veterans Affairs’ (VA) multi-billion dollar electronic health record (EHR) modernization program. In a unanimous 19-0 vote this week, lawmakers moved to compel the testimony of […]
The integration of automation in the healthcare sector has long been a subject of intense debate, often sparking fears that technology might eventually displace the human element essential to patient care. In nursing, a profession rooted in empathy and bedside presence, the prospect of "replacement" is frequently met with resistance. However, a shifting paradigm in […]
The United States Food and Drug Administration (FDA) has officially granted Breakthrough Device Designation to Nutromics for its innovative wearable sensor patch designed for the continuous, real-time monitoring of vancomycin levels. This regulatory milestone represents a significant advancement in the field of precision medicine, particularly for the management of high-risk patients in intensive care units […]
GenHealth.ai, a burgeoning healthcare technology startup specializing in the automation of complex medical administrative tasks, announced on Tuesday that it has successfully closed a $16.5 million Series A funding round. This latest injection of capital brings the company’s total funding to $30 million since its inception in 2023, signaling strong investor confidence in the potential […]
